Moderate evidence
More
Review of 18 studies finds AI cut prostate MRI reading time by up to 50%
Study title: AI-Assisted Interpretation of Prostate MRI: A Narrative Review
- Evidence type
- Systematic review or meta-analysis
- Sources
- 1 sourcePeer-reviewed
- Published
- 1 min read
- Truvace record
- TRV-2026-2975cite or check it
Study title: AI-Assisted Interpretation of Prostate MRI: A Narrative Review
A review of studies published between January 2023 and April 2025 looked at AI-assisted reading of prostate MRI. Eighteen of 157 screened studies qualified. Standalone AI systems reached AUCs of 0.77 to 0.91, and some occasionally outperformed radiologists.
Read the study abstract
Multiparametric MRI (mpMRI) improves detection of clinically significant prostate cancer (csPCa) but is limited by inter-reader variability. Artificial intelligence (AI) has been increasingly applied to prostate segmentation and lesion detection, with heterogeneous results. Concerns remain regarding generalizability, data set bias, and validation. This review summarizes recent evidence on AI-assisted prostate MRI interpretation, identifies knowledge gaps, and outlines directions for future research. A systematic…

The gain
A review of 18 studies found AI-radiologist prostate MRI reading cut interpretation time by up to 50%, and in active surveillance cohorts AI detected disease progression better than radiologists (AUC 0.86 vs 0.69).
In brief
Combining AI with radiologists improved agreement between readers, cut interpretation time by up to 50% and improved detection of equivocal PI-RADS 3 lesions. Junior and general radiologists gained the most in performance, confidence and reproducibility.
Results varied widely between studies, and the authors say generalizability, data set bias and validation remain open concerns. Wider clinical use would need large multicenter validation and outcome-based evaluation.
Main points
- The search covered PubMed and Google Scholar for January 2023 to April 2025; 18 of 157 screened studies met the inclusion criteria.
- Standalone AI had AUCs of 0.77 to 0.91, sensitivities of 65.4% to 96% and specificities of 77.6% to 91%.
- Hybrid AI-radiologist models improved inter-reader agreement and cut interpretation time by up to 50%.
- AI assistance improved detection accuracy for equivocal PI-RADS 3 lesions.
- In active surveillance cohorts, AI beat radiologists at detecting progression (AUC 0.86 vs 0.69), though specificity limitations persisted.
The full story
Multiparametric MRI improves detection of clinically significant prostate cancer but is limited by differences between readers. The review asked whether AI, used alone or alongside radiologists, helps with segmentation, lesion detection and diagnosis.
Studies included had to assess diagnostic performance of AI alone or with radiologists on biparametric or multiparametric prostate MRI. Reference lists were also checked manually.
Benefits were largest for junior and general radiologists, whose diagnostic performance, confidence and reproducibility improved with AI help. The authors conclude AI could improve detection efficiency and standardization, but outcome data are still needed.
Sources
1 on file- Journal of Computer Assisted Tomographydoi:10.1097/rct.0000000000001942
Talk it over
The review found AI cut prostate MRI reading time by up to 50% but also found sensitivity as low as 65.4% for some standalone systems. How would you weigh the time saved against that range?
Review of 18 studies finds AI cut prostate MRI reading time by up to 50%https://truvace.com/item/ai-assisted-interpretation-of-prostate-mri-a-narrative-review
The review found AI cut prostate MRI reading time by up to 50% but also found sensitivity as low as 65.4% for some standalone systems. How would you weigh the time saved against that range?
Answer in the threadOnly 18 of 157 screened studies qualified, and results varied widely between them. What does that mix of studies let us conclude about AI-assisted reading, and where does it stop?
Answer in the threadJunior and general radiologists gained the most in performance, confidence and reproducibility. Who might benefit less, and how could that change how AI is rolled out in a department?
Answer in the thread
If you have more time
The authors say wider use needs large multicenter validation and outcome-based evaluation. What would you look up to find out whether such studies have been done for prostate MRI?
Answer in the threadIn active surveillance cohorts AI detected progression better than radiologists (AUC 0.86 vs 0.69), though specificity limits persisted. How would a hospital you know decide whether to act on that result?
Answer in the thread
ace
What readers say